Diagnostic performance of MK and Flortaucipir tau PET for the biological staging of Alzheimer disease

Our results support that AA-2024 biological and clinical stages show similar clinical-biological concordance using either Flortaucipir or MK-6240, although this can vary based on methods tested in the study. The MBI and SCD clinical subgroups showed no difference of pathological burden to clinical stage 1, while SOCD transitional stage showed higher burden compared to stage 1.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70857_107236
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Diagnostic performance of MK and Flortaucipir tau PET for the biological staging of Alzheimer disease

Val J. Lowe, Dana Tudorascu, Madeleine Bloomquist, Tharick Ali Pascoal et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Diagnostic performance of MK and Flortaucipir tau PET for the biological staging of Alzheimer disease

Val J. Lowe, Dana Tudorascu, Madeleine Bloomquist, Tharick Ali Pascoal, Belén Pascual, Joseph C. Masdeu, Guilherme Bauer‐Negrini, Emma Patrice Ruppert, Matheus Scarpatto Rodrigues, Bruna Bellaver, Suzanne L. Baker, Firoza Zubeida Lussier, Hussein Zalzale, Markley Silva Oliveira, David Soleimani‐Meigooni, Pampa Saha, Juan M. Fortea, Hwamee Oh, Pamela C.L. Ferreira, Livia Amaral, Guilherme Povala, Carolina Soares, Rayan Mroué, Andreia Rocha, Marina Scop Madeiros, Brian A. Gordon, Pedro Rosa‐Neto
article en

Abstract

Our results support that AA-2024 biological and clinical stages show similar clinical-biological concordance using either Flortaucipir or MK-6240, although this can vary based on methods tested in the study. The MBI and SCD clinical subgroups showed no difference of pathological burden to clinical stage 1, while SOCD transitional stage showed higher burden compared to stage 1.

Alzheimer s & DementiaVol. 21(S3)
Universitat Autònoma de Barcelona (ES), Houston Methodist (US), Lawrence Berkeley National Laboratory (US), University of Pittsburgh (US), Washington University in St. Louis (US), Brown University (US), Hospital de Sant Pau (ES), Mayo Clinic in Arizona (US), McGill University (CA)
Openalex Percentile: Top 32%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.